跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,785 条关于
“RLS-2201”
全部
3,785
临床试验
2,300
药物
997
机构
24
资讯
464
6个月前
Patrys Initiates Manufacturing and FDA Engagement for Injectable Delirium Treatment RLS-2201
去年
ReAlta Life Sciences Doses First Patient in Phase 2 aGvHD Trial with RLS-0071
5个月前
Rubedo Life Sciences Reports Positive Phase 1 Results for First-in-Class GPX4 Modulator RLS-1496 in Dermatological Conditions
10个月前
Rubedo Life Sciences Partners with SVAX to Advance Anti-Aging Drug RLS-1496 in Middle East Phase 2 Trials
2个月前
CU Anschutz Launches Phase 2 Trial of CBD Formulation for Restless Legs Syndrome
去年
Rubedo Life Sciences Initiates First-Ever GPX4 Modulator Clinical Trial for Psoriasis and Skin Aging
去年
ReAlta to Present Phase 2 Clinical Data on Novel Anti-Inflammatory Therapy for Newborn Brain Injury at PAS 2025
去年
AASM Updates Restless Legs Syndrome Treatment Guidelines: Shifts Away from Dopamine Agonists
去年
Long-Term Safety of Omaveloxolone in Friedreich Ataxia Highlighted
去年
ReAlta Life Sciences Receives European Orphan Drug Designation for Graft-versus-Host Disease Treatment
第 1 页,共 47 页
上一页
下一页